Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 6/2020

01-06-2020 | Esophageal Cancer | Editorial

Paradox of age-specific incidence rates of second primary cancer in individuals with esophageal cancer

Author: Tomonori Yano

Published in: Journal of Gastroenterology | Issue 6/2020

Login to get access

Excerpt

Aging must be the leading cause of cancer in clinical. In recent, translational research using samples of esophageal epithelium suggests that carcinogenesis of esophageal squamous cell carcinoma (ESCC) is related to age-related expansion of NOTCH1 mutated clones associated with exposure to large amounts of tobacco and alcohol consumption [1]. …
Literature
1.
Yokoyama A, Kakiuchi N, Yoshizato T, et al. Age-related remodeling of oesophageal epithelia by mutated cancer drivers. Nature. 2019;565:312–7.CrossRef
2.
3.
Matsubara T, Yamada K, Nakagawa A, et al. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;1(21):4336–411.CrossRef
4.
Muto M, Nakane M, Katada C, et al. Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites. Cancer. 2004;15(101):1375–81.CrossRef
5.
Muto M, Minashi K, Yano T, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010;20(28):1566–72.CrossRef
6.
Morimoto H, Yano T, Yoda Y, et al. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma. World J Gastroenterol. 2017;14(23):1051–8.CrossRef
7.
Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology. 2016;151:860–9 (e7).CrossRef
8.
Abiko S, Shimizu Y, Miyamoto S, et al. Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk. J Gastroenterol. 2018;53:1120–30.CrossRef
9.
Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;13(345):784–9.CrossRef
10.
Fenoglio-Preiser C, Carneiro F, Correa R, et al. Gastric carcinoma world health organization classification of tumors pathology and genetics of tumors of the digestive system. 2000; p. 39–52
11.
Hayakawa Y, Sethi N, Sepulveda AR, et al. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev. 2016;16:305–18.CrossRef
12.
Cancer Genome Atlas Research Network, et al. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–9.CrossRef
Metadata
Title
Paradox of age-specific incidence rates of second primary cancer in individuals with esophageal cancer
Author
Tomonori Yano
Publication date
01-06-2020
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 6/2020
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-020-01687-7

Other articles of this Issue 6/2020

Journal of Gastroenterology 6/2020 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study

Review

Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities

Original Article—Liver, Pancreas, and Biliary Tract

Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies

Original Article—Liver, Pancreas, and Biliary Tract

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial

Correction

Correction to: Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy

Review

Objective evaluation for treat to target in Crohn’s disease
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits